Scientists funded by the Medical Research Council (MRC) have identified a new type of bone marrow stem cell in mice that is primed to produce large numbers of vital blood-clotting platelets. The breakthrough may eventually lead to the development of new treatments to restore platelets in patients who have undergone chemotherapy or a bone marrow transplant. The research, published in Nature, was led by the MRC Weatherall Institute of Molecular Medicine (WIMM), at the University of Oxford.
↧